Immunization, Vaccines and Biologicals


10 June 2014

Young girl receives HPV vaccine
WHO/C. McNab

Hundreds of thousands of cases of, and deaths from cervical cancer worldwide can be prevented by vaccinating 12-year old girls against the cancer-causing human papillomaviruses (HPV), according to a study published in The Lancet Global Health today. The study also showed that HPV vaccination is likely to be cost effective in almost every country in the world. The authors of the study developed the Papillomavirus Rapid Interface for Modelling and Economics (PRIME), which is a simple analytical tool that it is straightforward enough to be used by non-experts, has fairly light data requirements and can be used and understood in different country settings.

Fact sheets

Fact sheets on vaccines and immunization

Millennium Development Goals

Immunization's contribution to reaching the Millennium Development Goal on child survival

News archive

Immunization newsroom stories featured over the last five years

Immunization highlights

An overview of key achievements by WHO and partners in the area of immunization. Now published annually


Calendar of key immunization events and features on vaccine and report launches, exhibits and advocacy efforts

Communication products

Key resources and other documentation pertinent to our immunization work